Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research And Development Co. Ltd.
David Wallach
Mark Boldin
Igor Mett
Eugene Varfolomeev
Yeda Research And Development Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL109632Aexternal-prioritypatent/IL109632A/en
Priority claimed from IL11112594Aexternal-prioritypatent/IL111125A0/xx
Application filed by Yeda Research And Development Co. Ltd., David Wallach, Mark Boldin, Igor Mett, Eugene Varfolomeev, Yeda Research And Development Co., Ltd.filedCriticalYeda Research And Development Co. Ltd.
Publication of CA2490080A1publicationCriticalpatent/CA2490080A1/fr
CA002490080A1994-05-111995-05-11Modulateur de recepteurs de la super-famille tnf/ngf et recepteurs oligomeres solubles de la super-famille tnf/ngf
AbandonedCA2490080A1
(fr)
ПОЛИПЕПТИД, ОБЛАДАЮЩИЙ СПОСОБНОСТЬЮ СВЯЗЫВАТЬСЯ С ВНУТРИКЛЕТОЧНЫМ ДОМЕНОМ p-55 TNF-РЕЦЕПТОРА, МОЛЕКУЛА ДНК, КОДИРУЮЩАЯ ЭТОТ ПОЛИПЕПТИД, ВЕКТОР ЭКСПРЕССИИ И СПОСОБ ПОЛУЧЕНИЯ ПОЛИПЕПТИДА
Молекула днк, кодирующая полипептид, способный связываться с внутриклеточным доменом рецептора лиганда fas(fas-ic), полипептид, способ его получения, вектор, способ модуляции действия лиганда fas-r на клетки (варианты), фармацевтическая композиция (варианты), спрособ выделения и идентификации белка